MarketBeat Instant News Alerts 2 hours agoBig Technologies (LON:BIG) Issues Earnings ResultsMarketBeatBig Technologies (LON:BIG - Get Free Report) announced its earnings results on Tuesday. The company reported GBX (10) earnings per share for the quarter. Big Technologies had a net margin of 23.01% and a return on equity of 9.67%. LON:BIGRead Big Technologies (LON:BIG) Issues Earnings Results2 hours agoCard Factory (LON:CARD) Announces Earnings ResultsMarketBeatCard Factory (LON:CARD - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX 2.80 earnings per share (EPS) for the quarter. Card Factory had a net margin of 7.79% and a return on equity of 13.00%. LON:CARDRead Card Factory (LON:CARD) Announces Earnings Results2 hours agoClose Brothers Group (LON:CBG) Posts Quarterly Earnings ResultsMarketBeatClose Brothers Group (LON:CBG - Get Free Report) issued its earnings results on Tuesday. The company reported GBX 59.30 earnings per share for the quarter. Close Brothers Group had a return on equity of 5.78% and a net margin of 7.79%.LON:CBGRead Close Brothers Group (LON:CBG) Posts Quarterly Earnings Results2 hours agoKEFI Gold and Copper (LON:KEFI) Releases Earnings ResultsMarketBeatKEFI Gold and Copper (LON:KEFI - Get Free Report) posted its earnings results on Tuesday. The company reported GBX (0.05) earnings per share for the quarter. LON:KEFIRead KEFI Gold and Copper (LON:KEFI) Releases Earnings Results2 hours agoVenture Life Group (LON:VLG) Issues Quarterly Earnings ResultsMarketBeatVenture Life Group (LON:VLG - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported GBX 0.83 earnings per share (EPS) for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. LON:VLGRead Venture Life Group (LON:VLG) Issues Quarterly Earnings Results2 hours agoAvalo Therapeutics' (AVTX) Buy Rating Reiterated at BTIG ResearchMarketBeatBTIG Research reissued a "buy" rating and issued a $40.00 target price on shares of Avalo Therapeutics in a report on Monday.NASDAQ:AVTXRead Avalo Therapeutics' (AVTX) Buy Rating Reiterated at BTIG Research Trending News1Plug Power, Inc. $PLUG Shares Acquired by Brave Asset Management Inc.2NVIDIA (NASDAQ:NVDA) Stock Price Down 89.8% After Insider Selling3Investors Purchase High Volume of Call Options on PayPal (NASDAQ:PYPL)4NVIDIA's (NVDA) "Buy" Rating Reiterated at Jefferies Financial Group5Top Chinese Stocks To Watch Today - September 27th6Diageo (NYSE:DEO) Given New $109.00 Price Target at Bank of America7Top Penny Stocks To Keep An Eye On - September 28th8Patton Fund Management Inc. Takes Position in Dominion Energy Inc. $D All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoAnaptysBio (NASDAQ:ANAB) Price Target Raised to $59.00 at HC WainwrightMarketBeatNASDAQ:ANABRead AnaptysBio (NASDAQ:ANAB) Price Target Raised to $59.00 at HC Wainwright2 hours agoWedbush Reiterates "Outperform" Rating for AnaptysBio (NASDAQ:ANAB)MarketBeatNASDAQ:ANABRead Wedbush Reiterates "Outperform" Rating for AnaptysBio (NASDAQ:ANAB)2 hours agoBeyond Meat (NASDAQ:BYND) Earns "Neutral" Rating from BTIG ResearchMarketBeatNASDAQ:BYNDRead Beyond Meat (NASDAQ:BYND) Earns "Neutral" Rating from BTIG Research2 hours agoMaplebear's (CART) Neutral Rating Reaffirmed at BTIG ResearchMarketBeatNASDAQ:CARTRead Maplebear's (CART) Neutral Rating Reaffirmed at BTIG Research2 hours agoNeedham & Company LLC Boosts Cipher Mining (NASDAQ:CIFR) Price Target to $15.00MarketBeatNASDAQ:CIFRRead Needham & Company LLC Boosts Cipher Mining (NASDAQ:CIFR) Price Target to $15.002 hours agoCoya Therapeutics (NASDAQ:COYA) Receives Buy Rating from BTIG ResearchMarketBeatNASDAQ:COYARead Coya Therapeutics (NASDAQ:COYA) Receives Buy Rating from BTIG Research2 hours agoCoreWeave (NASDAQ:CRWV) Earns Outperform Rating from Analysts at Evercore ISIMarketBeatNASDAQ:CRWVRead CoreWeave (NASDAQ:CRWV) Earns Outperform Rating from Analysts at Evercore ISI2 hours agoEnanta Pharmaceuticals (NASDAQ:ENTA) Price Target Raised to $28.00MarketBeatNASDAQ:ENTARead Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target Raised to $28.002 hours agoElbit Systems (NASDAQ:ESLT) Now Covered by Analysts at JPMorgan Chase & Co.MarketBeatNASDAQ:ESLTRead Elbit Systems (NASDAQ:ESLT) Now Covered by Analysts at JPMorgan Chase & Co.2 hours agoRobinhood Markets (NASDAQ:HOOD) Given New $145.00 Price Target at Needham & Company LLCMarketBeatNASDAQ:HOODRead Robinhood Markets (NASDAQ:HOOD) Given New $145.00 Price Target at Needham & Company LLC2 hours agoD. Boral Capital Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)MarketBeatNASDAQ:HUMARead D. Boral Capital Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)2 hours agoImmuneering (NASDAQ:IMRX) Given "Buy" Rating at HC WainwrightMarketBeatNASDAQ:IMRXRead Immuneering (NASDAQ:IMRX) Given "Buy" Rating at HC Wainwright2 hours agoKura Oncology's (KURA) "Buy" Rating Reaffirmed at HC WainwrightMarketBeatNASDAQ:KURARead Kura Oncology's (KURA) "Buy" Rating Reaffirmed at HC Wainwright2 hours agoLantronix (NASDAQ:LTRX) Price Target Raised to $5.50MarketBeatNASDAQ:LTRXRead Lantronix (NASDAQ:LTRX) Price Target Raised to $5.502 hours agoNeedham & Company LLC Has Lowered Expectations for MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock PriceMarketBeatNASDAQ:MLTXRead Needham & Company LLC Has Lowered Expectations for MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price2 hours agoMerus (NASDAQ:MRUS) Receives "Market Perform" Rating from Lifesci CapitalMarketBeatNASDAQ:MRUSRead Merus (NASDAQ:MRUS) Receives "Market Perform" Rating from Lifesci Capital2 hours agoWells Fargo & Company Reiterates "Equal Weight" Rating for Strategy (NASDAQ:MSTR)MarketBeatNASDAQ:MSTRRead Wells Fargo & Company Reiterates "Equal Weight" Rating for Strategy (NASDAQ:MSTR)2 hours agoNovoCure's (NVCR) "Neutral" Rating Reaffirmed at WedbushMarketBeatNASDAQ:NVCRRead NovoCure's (NVCR) "Neutral" Rating Reaffirmed at Wedbush2 hours agoJefferies Financial Group Issues Pessimistic Forecast for Progress Software (NASDAQ:PRGS) Stock PriceMarketBeatNASDAQ:PRGSRead Jefferies Financial Group Issues Pessimistic Forecast for Progress Software (NASDAQ:PRGS) Stock Price2 hours agoSailPoint's (SAIL) Buy Rating Reiterated at BTIG ResearchMarketBeatNASDAQ:SAILRead SailPoint's (SAIL) Buy Rating Reiterated at BTIG Research2 hours agoHC Wainwright Initiates Coverage on Skye Bioscience (NASDAQ:SKYE)MarketBeatNASDAQ:SKYERead HC Wainwright Initiates Coverage on Skye Bioscience (NASDAQ:SKYE)2 hours agoCanaccord Genuity Group Forecasts Strong Price Appreciation for Tesla (NASDAQ:TSLA) StockMarketBeatNASDAQ:TSLARead Canaccord Genuity Group Forecasts Strong Price Appreciation for Tesla (NASDAQ:TSLA) Stock2 hours agoCICC Research Initiates Coverage on Take-Two Interactive Software (NASDAQ:TTWO)MarketBeatNASDAQ:TTWORead CICC Research Initiates Coverage on Take-Two Interactive Software (NASDAQ:TTWO)2 hours agoUSA Rare Earth (NASDAQ:USAR) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysMarketBeatNASDAQ:USARRead USA Rare Earth (NASDAQ:USAR) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says Featured Articles and OffersSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025Your Bank Account Is No Longer SafeFrom Priority Gold (Ad)3 Quantum Computing ETFs to Know—And Why 2 Don't Hold D-WaveBy Nathan Reiff | September 23, 2025Is Super Micro Next in Line for a Big AI Takeover?By Gabriel Osorio-Mazilli | September 23, 2025Downgraded But Not Done: 3 Stocks Ready for a Market ComebackBy Thomas Hughes | September 24, 2025Defense Billions Flow Into Critical Minerals — Here’s Why Gold’s KeyFrom The Tomorrow Investor (Ad)Qualcomm’s RSI Just Hit Its High of the Year—Why That’s BullishBy Sam Quirke | September 24, 2025Tesla: 3 Reasons October’s Earnings Will Make or Break the StockBy Sam Quirke | September 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
